The correlation between the upfront time to build and release a clinical database and its impact on downstream data management.

Learn how biotechnology trials are transforming clinical data management systems, leveraging machine learning and advanced protocols to enhance efficiency and accuracy in data collection and analysis.

Bain Capital, Blackstone, KKR and Advent International are among the PE firms buying or selling patient engagement technology assets.

The purpose of leveraging wearables is to promote better outcomes. Model tests offer a way to link reimbursement to ...

Kathrin Forrest of Capital Group says constraints include supply of human capital and computer chips, and the build-out of ...

The pandemic was a catalyst for growing popular interest in robotics, and for shining a spotlight on the skilled labour shortages.

The VA has embarked on a biometric experiment that could reshape how tens of thousands of its healthcare staff access ...

He was previously a senior lecturer at the University of Surrey and a research fellow of the Surrey Centre for Law and Philosophy, as well as a faculty fellow in the Law and Philosophy Program at the ...

Explore the current state of AI in drug discovery and the challenges impacting its adoption and effectiveness in pharmaceuticals.

In rare disease, the European long-read innovation network, advanced delivery of its 10,000 genome program over 3 years, working to a transition from short-read sequencing to Oxford Nanopore's ...

Objective Comprehensive data and analyses on cardiovascular research could clarify recent research trends for the academic community and facilitate policy development. We examined publications and ...